Phase IIb Study of MP4OX in Traumatic Hemorrhagic Shock Patients

Clinical trial NCT01262196 · COMPLETED

Trial details

NCT number: NCT01262196
Sponsor: Sangart
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Shock, Hemorrhagic Shock, Traumatic Acidosis, Lactic

Start date: 2011-05-01
Primary completion: 2012-10-01
Enrollment: 348

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.